Sign In
Buy KVUE
$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
Kenvue quarterly sales rise on strong demand for self-care products
06:23am, Thursday, 20'th Jul 2023
Kenvue on Thursday posted a rise in quarterly sales thanks to strong demand for its self-care and skincare brands such as Tylenol and Neutrogena.
3 Healthcare Stocks to Buy as the Market Gets Defensive
12:33am, Tuesday, 18'th Jul 2023
With so much concern about the Federal Reserve and its decision-making implications for forward market trends, investors may do well targeting healthcare stocks. Fundamentally, the underlying sector r
IPO Market Showing Signs Of Life, Drawing Second-Half Optimism On Wall Street
02:15am, Friday, 14'th Jul 2023
The last 18 months have been like an ice age for investment bankers brokering deals and young business owners looking to tap extra capital. Several successful recent IPOs may foster green shoots for f
Like shoppers, IPO investors are demanding discounts and showing price sensitivity
12:17pm, Friday, 30'th Jun 2023
IPO investors, much like shoppers in the current inflationary environment, are demanding clear discounts and demonstrating sensitivity to price and valuations, according to Renaissance Capital.
7 Up-and-Coming Stocks to Buy for the Next Decade
04:49pm, Thursday, 29'th Jun 2023
In arguably most cases involving expert financial advice, you will encounter guidance toward established enterprises, not up-and-coming stocks to buy. While the latter category certainly dials up the
Kenvue to Announce Second Quarter 2023 Results on July 20, 2023
04:30pm, Tuesday, 06'th Jun 2023
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) announced financial results for the second quarter ending July 2, 2023, will be released before market open July 20, 2023.
1 Ultra-Elite Dividend Stock to Buy Hand Over Fist in June
07:36am, Sunday, 04'th Jun 2023
Johnson & Johnson offers a higher dividend yield. It backs that payout with an elite financial profile.
Kenvue's stock hits fresh post-IPO lows as Tylenol parent company receives tepid reviews from analysts
03:27pm, Tuesday, 30'th May 2023
Shares of Kenvue Inc. plumbed new lows after Wall Street analysts started coverage of the consumer household-brands company and Johnson & Johnson spinoff with halfhearted ratings, saying bullish funda
Kenvue is a “show me story” after strong start following J&J spinoff
02:45pm, Tuesday, 30'th May 2023
UBS analysts initiated coverage of Kenvue Inc (KVUE), the recent spinoff of Johnson & Johnson (NYSE:JNJ)'s consumer brand segment, with a ‘Neutral' rating and a 12-month target price of $28 per shar
7 Consumer Stocks to Buy and Hold for the Long Haul
07:15pm, Monday, 29'th May 2023
When it comes to building a strong portfolio, it's wise to include some of the best long-term consumer stocks. In fact, there are two key reasons for this.
Kenvue Just IPO'd, but Is the Stock a Buy?
05:24am, Friday, 19'th May 2023
Kenvue is now independent of Johnson & Johnson (sort of). It needs to demonstrate that nothing important has changed since the spinoff.
2 Dividend Stocks to Double Up On Right Now
08:35am, Wednesday, 17'th May 2023
Falling share prices have pushed up the dividend yields on several high-quality companies. Johnson & Johnson currently yields around 3%.
Kenvue Has Gone Public: Should You Buy the Stock?
09:38am, Tuesday, 16'th May 2023
Shares of Kenvue went public last week as Johnson & Johnson spun off its consumer health business. The new company markets some strong brands, including Tylenol, Nicorette, Motrin, and many others.
J&J Kenvue Spinoff Aims To Give Investors A Healthy Return
07:48am, Tuesday, 09'th May 2023
This year hasn't been the most active when it comes to initial public offerings, but Johnson & Johnson NYSE: JNJ spinoff Kenvue Inc. NYSE: KVUE set a bar, of sorts, with the biggest IPO since Rivian A
U.S. IPO Weekly Recap: Kenvue And ACELYRIN Fire Up The IPO Market, Raising A Combined $4.3 Billion
08:08am, Sunday, 07'th May 2023
The month of May started off with two large IPOs, Kenvue and ACELYRIN. Two blank check IPOs also priced this past week.
